hotspot -WSS

hotspot

author：hotspot 2025-08-23 08:57:46 - browse：58641

Mifepristone (Mifeprex) and Misoprostol — A federal appeals court on Wednesday ruled to restrict access to the abortion pill mifepristone but not remove it from the market entirely. ROBYN BECK/AFP via Getty Images

A federal appeals court on Wednesday ruled to restrict access to the abortion pill mifepristone but not remove it from the market entirely, partially upholding a lower court’s decision.

The decision from the three-judge panel of the 5th U.S. Circuit Court of Appeals would effectively block mail-order prescriptions of the pill. However, access will remain unchanged for now, as the Supreme Court issued an emergency order this spring to preserve the status quo while the case goes through the appeals process.

The case is all but assured to head to the highest court, which last year overturned Roe v. Wade. Since the ruling, 14 states have implemented abortion bans and another 11 have imposed limits, some up to six weeks of pregnancy.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： The Sacklers, horror, and ‘The Fall of the House of Usher’

WSS

Removing probiotics from the NICU could threaten preemies' health

A clever new way to fix Medicaid and graduate medical education

Leukemia patients are helped by Syndax's new type of therapy

More doctors should go into startup world

FDA needs staff influx to meet gene therapy needs, Marks says

Removing probiotics from the NICU could threaten preemies' health

Wikipedia

hotspot

hotspot

Duchenne breakthrough therapy leaves behind pioneering families

Pfizer plans to depart BIO

Moonlake's readout produced a cash windfall. Risks remain

Pharma patents targeted by Biden in move to slash drug prices

Hollywood unions extend contract negotiations for actors

Spinal cord stimulation reduces pain in amputees, study finds

Jerome Adams on the need for new antivirals for Covid

Diversify hospital leadership teams to protect BIPOC patient health

Affirmative action in medical school literally saved lives

MoonLake credibility takes another hit with mid

focus

Supreme Court wrestles with OxyContin maker's bankruptcy deal

Congenital heart disease patients face new threat of heart failure

Leukemia patients are helped by Syndax's new type of therapy

Senate panel clears PBM, hopsital reforms

STAT letters to the editor on burnt

FDA approves potent Eli Lilly obesity drug, Zepbound

hotspot

entertainment

focus

leisure time